Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
A Novel Anionic Nanoparticle Delivery System for Microrna-29b Targets FLT3 and KIT Receptor Tyrosine Kinase Expression in Acute Myeloid Leukemia
A Novel Anionic Nanoparticle Delivery System for Microrna-29b Targets FLT3 and KIT Receptor Tyrosine Kinase Expression in Acute Myeloid Leukemia
A Novel Anionic Nanoparticle Delivery System for Microrna-29b Targets FLT3 and KIT Receptor Tyrosine Kinase Expression in Acute Myeloid Leukemia
Huang, X. (Autor:in) / Schwind, S. (Autor:in) / Yu, B. (Autor:in) / Liu, S. (Autor:in) / Pang, J. (Autor:in) / Santhanam, R. (Autor:in) / Wu, Y.-Z. (Autor:in) / Chan, K.K. (Autor:in) / Blum, W. (Autor:in) / Bloomfield, C.D. (Autor:in)
Nanoscale science and engineering forum ; 2012 ; Pittsburgh, PA
Nanoscale science and engineering forum ; 376-377
01.01.2013
2 pages
Includes bibliographical references and index
Aufsatz (Konferenz)
Englisch
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
Europäisches Patentamt | 2019
|QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS
Europäisches Patentamt | 2017
|